Quinoline or isoquinoline substituted P2X7 antagonists

Details for Australian Patent Application No. 2009239471 (hide)

Owner Janssen Pharmaceutica NV

Inventors Love, Christopher John; Rech, Jason Christopher; Lebsack, Alec Donald; Venable, Jennifer Diane; Branstetter, Bryan James; Smith, Deborah Margaret; Breitenbucher, James Guy; Gleason, Elizabeth Ann; Leenaerts, Joseph Elisabeth; Cooymans, Ludwig Paul; Wiener, Danielle

Agent Shelston IP

Pub. Number AU-A-2009239471

PCT Pub. Number WO2009/132000

Priority 08154909.9 22.04.08 EP

Filing date 21 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/132000 Priority application(s): WO2009/132000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239472-Drive system

2009239469-Acetaminophen-protein adduct assay device and method